CPT Codes For Immunization Administration For Vaccines/Toxoids

Below is a list summarizing the CPT codes for immunization administration for vaccines/toxoids.

CPT Code 0001A

CPT 0001A describes immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative-free, 30 mcg/0.3 mL dosage; diluent reconstituted for the first dose.

CPT Code 0002A

CPT 0002A describes the administration of a second dose of a preservative-free, 30 mcg/0.3 mL dosage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, by intramuscular injection.

CPT Code 0003A

CPT 0003A describes the administration of a third dose of a preservative-free, 30 mcg/0.3 mL dosage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, by intramuscular injection.

CPT Code 0004A

CPT 0004A describes immunization administration of a booster dose of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative-free, 30 mcg/0.3 mL dosage, with diluent reconstituted.

CPT Code 0011A

CPT 0011A describes immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative-free, 100 mcg/0.5 mL dosage for the first dose.

CPT Code 0012A

CPT 0012A describes the immunization administration of a second dose of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative-free, 100 mcg/0.5 mL dosage, by intramuscular injection.

CPT Code 0013A

CPT 0013A describes the administration of a third dose of a preservative-free, 100 mcg/0.5 mL dosage of mRNA-LNP, spike protein severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine by intramuscular injection.

CPT Code 0021A

CPT 0021A describes immunization administration by intramuscular injection of a preservative-free, 5×1010 viral particles/0.5 mL dosage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, and chimpanzee adenovirus Oxford 1 (ChAdOx1) vector for the first dose.

CPT Code 0022A

CPT 0022A describes the immunization administration of a preservative-free, 0.5 mL dosage of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, containing DNA spike protein and chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, at 5×1010 viral particles, for a second dose.

CPT Code 0031A

CPT 0031A describes immunization administration by intramuscular injection of a single dose of a preservative-free SARS-CoV-2 (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, with a dosage of 5×1010 viral particles/0.5 mL.

CPT Code 0044A

CPT 0044A describes immunization administration of a recombinant spike protein nanoparticle, saponin-based adjuvant, preservative-free, five mcg/0.5 mL dosage; booster dose of severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine.

CPT Code 0071A

CPT 0071A describes immunization administration by intramuscular injection of the first dose of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative-free, ten mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation.

CPT Code 0072A

CPT 0072A describes immunization administration by intramuscular injection of a second dose of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative-free, ten mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation.

CPT Code 0073A

CPT 0073A describes the administration of a third dose of a preservative-free, mRNA-LNP, spike protein, SARS-CoV-2 (coronavirus disease [COVID-19]) vaccine, with a ten mcg/0.2 mL dosage, reconstituted with tris-sucrose formulation, by intramuscular injection.

CPT Code 0074A

CPT 0074A describes immunization administration of a booster dose of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative-free, ten mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, by intramuscular injection.

CPT Code 0081A

CPT 0081A describes immunization administration by intramuscular injection of the first dose of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative-free, three mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation.

CPT Code 0082A

CPT 0082A describes the administration of a second dose of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative-free, three mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, by intramuscular injection.

CPT Code 0083A

CPT 0083A describes the administration of a third dose of a preservative-free, tris-sucrose formulation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, with a three mcg/0.2 mL dosage, after diluent has been reconstituted.

CPT Code 0091A

CPT 0091A describes immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative-free, 50 mcg/0.5 mL dosage, for the first dose when administered to individuals 6 through 11 years.

CPT Code 0092A

CPT 0092A describes immunization administration by intramuscular injection of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative-free, 50 mcg/0.5 mL dosage for a second dose when administered to individuals 6 through 11 years.

CPT Code 0093A

CPT 0093A describes the immunization administration of a third dose of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative-free, 50 mcg/0.5 mL dosage when administered to individuals 6 through 11 years.

CPT Code 0104A

CPT 0104A describes immunization administration of a monovalent, preservative-free SARS-CoV-2 (coronavirus disease [COVID-19]) vaccine with a five mcg/0.5 mL dosage of an adjuvant AS03 emulsion booster dose by intramuscular injection.

CPT Code 0111A

CPT 0111A describes immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative-free, 25 mcg/0.25 mL dosage for the first dose.

CPT Code 0112A

CPT 0112A describes the immunization administration of a second dose of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative-free, 25 mcg/0.25 mL dosage, by intramuscular injection.

CPT Code 0113A

CPT 0113A describes the administration of a third dose of a preservative-free, 25 mcg/0.25 mL dosage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, by intramuscular injection.

CPT Code 0124A

CPT 0124A describes immunization administration by intramuscular injection of a preservative-free, tris-sucrose formulation of a bivalent spike protein mRNA-LNP SARS-CoV-2 (coronavirus disease [COVID-19]) vaccine with a 30 mcg/0.3 mL dosage, as a booster dose.

CPT Code 0134A

CPT 0134A describes immunization administration by intramuscular injection of a preservative-free, bivalent, mRNA-LNP, spike protein SARS-CoV-2 (coronavirus disease [COVID-19]) vaccine, with a dosage of 50 mcg/0.5 mL, for a booster dose.

CPT Code 0144A

CPT 0144A describes immunization administration of a booster dose of a preservative-free, bivalent, mRNA-LNP, spike protein SARS-CoV-2 (coronavirus disease [COVID-19]) vaccine with a 25 mcg/0.25 mL dosage by intramuscular injection.

CPT Code 0154A

CPT 0154A describes immunization administration by intramuscular injection of a preservative-free, bivalent spike protein, mRNA-LNP, SARS-CoV-2 (coronavirus disease [COVID-19]) vaccine, with a ten mcg/0.2 mL dosage, tris-sucrose formulation, and a booster dose.

CPT Code 0173A

CPT 0173A describes immunization administration by intramuscular injection of a preservative-free, tris-sucrose formulation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, with a dosage of 3 mcg/0.2 mL, and a third dose of diluent reconstituted.

CPT Code 90460

CPT 90460 describes immunization administration through 18 years of age via any route of administration, with counseling by a physician or other qualified health care professional, and the first or only component of each vaccine or toxoid administered.

CPT Code 90471

CPT 90471 describes the administration of a single or combination vaccine/toxoid, including percutaneous, intradermal, subcutaneous, or intramuscular injections.

CPT Code 90473

CPT 90473 describes immunization administration by the intranasal or oral route of a single or combination vaccine/toxoid.